MetaCap

Innate Pharma S.A. Statistics

NASDAQ: IPHAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

0.8634-0.0765 (-8.14%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Innate Pharma S.A. by the numbers

Innate Pharma S.A. has a market capitalization of $96.4 million based on 111.70M shares outstanding. With trailing EPS of $-0.59, Innate Pharma S.A. is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 43.7% below its 50-day average and 48.6% below its 200-day average.

Average daily trading volume is 42.76K shares, or about $36,921 in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

IPHA valuation vs. peer median

IPHA compared with the median of 8 peer companies
MetricIPHAPeer medianDifference
Market cap$96.44M$96.00M+0%
Avg. volume42.76K1.05M-96%

Peer median across 8 companies: MOLN, VYGR, OTLK, LENZ, ZURA, CRDL, FATE, ARMP.

Valuation

Price and trading

Previous close
0.9399
Open
0.8841
Day range
0.829 – 0.9084
52-week range
0.829 – 2.71
52-week change
-52.56%
Beta
—
Volume
18.03K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
96.44M
Forward Pe
-1.86
Eps
-0.59
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
2.71
Week52 Low
0.83
Avg Volume
42,762.00
Shares Outstanding
111.70M
Ma50
1.53
Ma200
1.68
Earnings Date
Nov 5, 2026
Pct From52w High
-68.14%
Pct From52w Low
4.15%

Related